← Eichor
Condition: Small Vessel Cerebrovascular Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Small Vessel Cerebrovascular Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06090201A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeedin
Phase N/A · 1 location(s) · Amicus Therapeutics · NCT04252066The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke
Phase N/A · 1 location(s) · University of Leicester · NCT06354881Dementia Risk Registry for Young and Middle-aged CSVD Patients in the Next 10 Years
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06164262Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
NA · 1 location(s) · University Health Network, Toronto · NCT04856059Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06031610Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation
NA · 2 location(s) · University of Coimbra · NCT07329647Imaging the Pathogenesis of Cerebral Small Vessel Disease
Phase N/A · 1 location(s) · Johns Hopkins University · NCT05703386Study On the Expression Level and Clinical Significance of VISTA in Patients With Vascular Cognitive Impairment
Phase N/A · 1 location(s) · First Affiliated Hospital of Harbin Medical University · NCT06342661Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease
NA · 1 location(s) · Imperial College London · NCT06643013Prognosis of Cerebral Small Vessel Disease
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05734378Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
Phase N/A · 7 location(s) · Chiesi Italia · NCT07109375KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3 · 10 location(s) · Khondrion BV · NCT06451757Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06715007Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
Phase N/A · 2 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06938100Registry Study of Cerebral Small Vessel Disease
Phase N/A · 1 location(s) · Dongzhimen Hospital, Beijing · NCT07342075Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease
Phase 2/Phase 3 · 10 location(s) · Chiesi Farmaceutici S.p.A. · NCT05710692Evaluation of HEArt invoLvement in Patients With FABRY Disease
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT03362164Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565Cerebral Small Vessel Disease Progression Dependent on Stroke Type
Phase N/A · 1 location(s) · Johannes Dorst · NCT07611136Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
Phase 3 · 2 location(s) · Ottawa Hospital Research Institute · NCT06983821Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)
NA · 2 location(s) · Tongji Hospital · NCT06474507Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal
Phase N/A · 2 location(s) · University of Minnesota · NCT01581424Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Phase N/A · 12 location(s) · University of Wisconsin, Madison · NCT05677880WHIte MAtter Hyperintensity Shape and Glymphatics
Phase N/A · 1 location(s) · Leiden University Medical Center · NCT06010511Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Phase 2 · 35 location(s) · Novartis Pharmaceuticals · NCT06868290A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polypheno
NA · 1 location(s) · Fundación Pública Andaluza para la gestión de la Investigaci · NCT07353424Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Phase 4 · 22 location(s) · Chiba University · NCT06611696Retina is a Marker for Cerebrovascular Heath
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT04753970Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07382128
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.